Since she was at high risk for developing breast cancer as a carrier of a BRCA2 pathogenic variant, we performed core needle biopsy of the small breast mass with a 14-G needle after injecting local anesthetic subcutaneously and around the tumor under ultrasonographic guidance. This evidence concerns the gene BRCA2 and breast cancer.